Future medicine and diagnostic tools depend on a deep understanding of cellular and molecular processes, and the capability to translate novel findings into solutions for defined clinical problems. At the Department of Immunotechnology, we apply such strategies to selected focus areas such as immuno-oncology, biomarkers, and sensitization and collaborate with researchers and clinicians world-wide.
Research within this area is driven and made possible by collaboration with national and European infrastructures, and we host core-facilities within our key technology areas proteomics, antibody-engineering, and spatial omics.
We are proud to contribute to societal development through education, research, and innovations.
Professor Sara Ek has received 1.2 MSEK in support from LTH to participate in[...]
The parties have signed a 5-year collaboration agreement. Focus will be on[...]